Day OneTuesday, March 10, 2026 - ET (Eastern Time, GMT-05:00)

Join industry leaders for an insightful examination of the current global life science landscape, with a special focus on the United States' competitive position. This panel brings together experienced life science executives to provide a comprehensive view of funding trends and strategic opportunities

• Who is stepping up to fill gaps in early-stage funding, and what new investment models are emerging?
• Which life science companies and therapeutic areas are attracting investor capital in today's market?
• Practical strategies for companies to navigate and thrive in the current funding environment
• How has the rise of China as a life science powerhouse reshaped the global investment patterns, and where does the US and Europe stand in comparison?

South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is becoming a magnet for innovation and collaboration. This panel will delve into the key drivers behind South Florida’s rise, the opportunities it presents for investors and innovators, and the challenges that lie ahead in sustaining this momentum

• South Florida’s strategic role in global healthcare
• Insights into the capital influx, public-private partnerships, and infrastructure developments that are fuelling South Florida’s transformation
• The role of South Florida’s universities, research institutions, and healthcare organizations in fostering cutting-edge research and a skilled workforce
• Sustaining momentum and strategies to ensure South Florida's long-term success in the life sciences sector
  

Is your company’s intellectual property pieces of paper you pray never get a close look, or is it the true crown jewel of your business? This masterclass will address how biotechnology and pharmaceutical companies can turn IP from a defensive cost center into an offensive asset that attracts partnerships and makes every part of the business flourish

• Which markets are currently most desirable for startups and why?
• Navigating varied and complex regulatory requirements across China, Europe, and the Middle East
• Discussing the importance of forming local alliances and strategic collaboration partners
• Tailoring your business and commercialization plans to fit the unique dynamics of each regional market
• Understanding how to safeguard your intellectual property and comply with regional data privacy laws while expanding your global footprint

• Overview of the growth we’ve seen in the space in recent years
• Highlighting breakthroughs in diagnostics, therapeutics, and digital health solutions tailored to women’s needs
• Understand how investors are shifting focus toward women’s health and what it means for startups
• Discussing how low reimbursement rates affect women's health and what needs to be done to fix this
• A look at home advancing women's brain health is a strategic pathway to strengthening global brain care

• Strategies for securing investment in a competitive and evolving market
• Discussing the key metrics that define viability and ROI in TechBio
• Identify what sets strong TechBio companies apart from short-lived trends
• Examine the long-term potential of TechBio as a profitable business model
• Gain insights into what investors prioritize when evaluating TechBio opportunities

• How to adapt exit strategies in a cautious and unpredictable financial landscape
• Beyond the IPO - exploring alternative pathways to liquidity that are gaining traction in today’s market
• Advice from industry leaders on mastering your exit strategy in a shifting environment
• How to be “exit ready” at all times by maintaining strong financials, a clear growth narrative, and a well-defined plan for providing a return to stakeholders

As life sciences evolve, corporate venture capital (CVC) is becoming a critical driver of innovation. This panel brings together CVC leaders to share insights into their investment strategies, decision-making processes, and how startups can successfully engage with these global giants

• How do CVC’s balance strategic goals with financial returns?
• Understand the focus areas and key factors that guide CVC decision-making
• Building strong, mutually beneficial relationships with CVCs